These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20643483)

  • 1. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.
    Perlis RH; Purcell S; Fagerness J; Cusin C; Yamaki L; Fava M; Smoller JW
    Biol Psychiatry; 2007 Sep; 62(5):536-40. PubMed ID: 17300755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of cyclic adenosine monophosphate response element-binding protein gene and major depressive disorder].
    Liu XH; Xu YF; Cui DH; Jiang SD; Qian YP; Yu SY; Jiang KD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):263-6. PubMed ID: 20533262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
    Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
    World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.
    Carlberg L; Schosser A; Calati R; Serretti A; Massat I; Papageorgiou K; Kocabas NA; Mendlewicz J; Zohar J; Montgomery SA; Souery D; Kasper S
    Int J Neurosci; 2015 May; 125(5):336-43. PubMed ID: 24955721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
    Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
    Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice.
    Rosenhagen MC; Uhr M
    J Clin Psychopharmacol; 2010 Apr; 30(2):209-11. PubMed ID: 20520302
    [No Abstract]   [Full Text] [Related]  

  • 13. The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.
    Juhasz G; Dunham JS; McKie S; Thomas E; Downey D; Chase D; Lloyd-Williams K; Toth ZG; Platt H; Mekli K; Payton A; Elliott R; Williams SR; Anderson IM; Deakin JF
    Biol Psychiatry; 2011 Apr; 69(8):762-71. PubMed ID: 21215389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
    Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
    Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
    Serretti A; Chiesa A; Crisafulli C; Massat I; Linotte S; Calati R; Kasper S; Bailer U; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Neuropsychobiology; 2012; 65(2):70-5. PubMed ID: 22222462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
    Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly.
    Cerri AP; Arosio B; Viazzoli C; Confalonieri R; Vergani C; Annoni G
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):219-23. PubMed ID: 19618378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
    Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
    Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
    Gratacòs M; Soria V; Urretavizcaya M; González JR; Crespo JM; Bayés M; de Cid R; Menchón JM; Vallejo J; Estivill X
    Pharmacogenomics J; 2008 Apr; 8(2):101-12. PubMed ID: 17505499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.